NewcelX Ltd.(NCEL)

Biotechnology · Kloten, ZH

$2.95+0.09 (+3.15%)

Delayed quote: Oct 6, 2026, 11:58 AM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T16:17:55.431Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:17:55.431Z.

Quote observation: 2026-10-06T15:58:56.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,327,500
Total debt · period ending 2026-06-30: 392,000
Cash · period ending 2026-06-30: 710,000
TTM operating income · period ending 2026-06-30: N/A

FMP input reference: ceb9d7bb150905ac81611c4688aa1bd793b2f4eb464ba4dc05e218b0340a6d90

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NCEL EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

NCEL Competitors' EV/EBIT Ratio

NCEL

NewcelX Ltd.

Current

Market Cap

$1.33M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNPX

Genprex, Inc.

vs NCEL

Market Cap

$1.36M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs NCEL

Market Cap

$1.24M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs NCEL

Market Cap

$1.40M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXGL

NEXGEL, Inc.

vs NCEL

Market Cap

$1.41M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IVF

INVO Fertility, Inc.

vs NCEL

Market Cap

$1.45M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PPCB

Propanc Biopharma, Inc.

vs NCEL

Market Cap

$1.18M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs NCEL

Market Cap

$1.47M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRIS

Curis, Inc.

vs NCEL

Market Cap

$1.48M

EV/EBIT Ratio

N/A

TTM Avg

439.92x

3Y Avg

439.92x

5Y Avg

439.92x

ELAB

PMGC Holdings Inc.

vs NCEL

Market Cap

$1.47M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
NewcelX Ltd. (NCEL)	$1.33M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.36M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.24M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.40M	N/A	N/A	N/A	N/A
NEXGEL, Inc. (NXGL)vs ›	$1.41M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.45M	N/A	N/A	N/A	N/A
Propanc Biopharma, Inc. (PPCB)vs ›	$1.18M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.47M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.48M	N/A	439.92x	439.92x	439.92x
PMGC Holdings Inc. (ELAB)vs ›	$1.47M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

NCEL EV/EBIT Ratio Metrics

NCEL Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics